Aortic stenosis pathophysiology

Jump to navigation Jump to search

Aortic Stenosis Microchapters

Home

Patient Information

Overview

Historical Perspective

Classification

Pathophysiology

Causes

Differentiating Aortic Stenosis from other Diseases

Epidemiology and Demographics

Risk Factors

Natural History, Complications and Prognosis

Diagnosis

History and Symptoms

Physical Examination

Cardiac Stress Test

Electrocardiogram

Chest X Ray

CT

MRI

Echocardiography

Cardiac Catheterization

Aortic Valve Area

Aortic Valve Area Calculation

Treatment

General Approach

Medical Therapy

Surgery

Percutaneous Aortic Balloon Valvotomy (PABV) or Aortic Valvuloplasty

Transcatheter Aortic Valve Replacement (TAVR)

TAVR vs SAVR
Critical Pathway
Patient Selection
Imaging
Evaluation
Valve Types
TAVR Procedure
Post TAVR management
AHA/ACC Guideline Recommendations

Follow Up

Prevention

Precautions and Prophylaxis

Cost-Effectiveness of Therapy

Future or Investigational Therapies

Case Studies

Case #1

Aortic stenosis pathophysiology On the Web

Most recent articles

Most cited articles

Review articles

CME Programs

Powerpoint slides

Images

American Roentgen Ray Society Images of Aortic stenosis pathophysiology

All Images
X-rays
Echo & Ultrasound
CT Images
MRI

Ongoing Trials at Clinical Trials.gov

US National Guidelines Clearinghouse

NICE Guidance

FDA on Aortic stenosis pathophysiology

CDC on Aortic stenosis pathophysiology

Aortic stenosis pathophysiology in the news

Blogs on Aortic stenosis pathophysiology

Directions to Hospitals Treating Aortic stenosis pathophysiology

Risk calculators and risk factors for Aortic stenosis pathophysiology

Editor-In-Chief: C. Michael Gibson, M.S., M.D. [1]; Associate Editors-In-Chief: Claudia P. Hochberg, M.D. [2], Abdul-Rahman Arabi, M.D. [3], Keri Shafer, M.D. [4], Priyamvada Singh, MBBS [5], Mohammed A. Sbeih, M.D. [6]; Assistant Editor-In-Chief: Kristin Feeney, B.S. [7]

Overview

Aortic stenosis results in the onset of a chronic pressure overload of the left ventricle. As the disease progresses, an aortic stenosis can result in compromised functional integrity of the surrounding mitral valve. The most common complication of aortic stenosis is left ventricular hypertrophy. Aortic stenosis could be subvalvular, supravalvular or at the level of the aortic valve.

Pathophysiology

When the aortic valve becomes stenosed, it can result in the formation of a pressure gradient between the left ventricle (LV) and the aorta [1]. The more constricted the valve, the higher the gradient between the LV and the aorta. For instance, with a mild AS, the gradient may be 20 mmHg. This means that, at peak systole, while the LV may generate a pressure of 140 mmHg, the pressure that is transmitted to the aorta will only be 120 mmHg. So, while a blood pressure cuff may measure a normal systolic blood pressure, the actual pressure generated by the LV would be considerably higher.

In individuals with AS, the left ventricle (LV) has to generate an increased pressure in order to overcome the increased afterload caused by the stenotic aortic valve and eject blood out of the LV. The more severe the aortic stenosis, the higher the gradient is between the left ventricular systolic pressures and the aortic systolic pressures. Due to the increased pressures generated by the left ventricle, the myocardium (muscle) of the LV undergoes hypertrophy (increase in muscle mass). This is seen as thickening of the walls of the LV. The type of hypertrophy most commonly seen in AS is concentric hypertrophy, meaning that all the walls of the LV are (approximately) equally thickened. As a result of increased the left ventricular wall thickness , the volume/mass ratio decreases, the compliance of the chamber also decreases, LV end-diastolic pressure increases without chamber dilatation [2]. Unfortunately, the adaptation to aortic stenosis by ventricular hypertrophy often carries adverse consequences. The hypertrophied heart may have reduced coronary blood flow even in the absence of coronary heart disease. This may lead to subendocardial ischemia during stress or exercise, which can contribute to systolic or diastolic dysfunction of the left ventricle [3][4]. Another factor that may reduce ventricular function is incoordinate contraction, resulting from regional wall motion abnormalities, fibrosis or ischemia.

In general, symptoms in patients with aortic stenosis and normal left ventricular systolic function rarely occur until the valve area is <1.0 cm2, the jet velocity is over 4.0 m/sec, and/or the mean transvalvular gradient exceeds 40 mmHg (table 2). However, many patients do not develop symptoms until even more severe valve obstruction is present, while some patients become symptomatic when the stenosis is less severe, particularly if there is coexisting aortic regurgitation.

Most patients with AS develop symptoms before the onset of left ventricular systolic dysfunction. However, in some patients, there is a reduction in systolic myocardial function and a decrease in the ability of the left ventricle to develop pressure and shorten against a load before the onset of symptoms. At this point, the left ventricle fails, resulting in reductions in stroke volume and cardiac output, and eventual heart failure. In addition, the marked elevation in left ventricular pressure can produce or exacerbate mitral regurgitation

In adults with AS, the obstruction develops gradually usually over decades. During this time, the left ventricle adapts to the systolic pressure overload through a hypertrophic process. However, if the hypertrophic process is inadequate and relative wall thickness does not increase in proportion to pressure, wall stress increases and the high afterload causes a decrease in ejection fraction [5]. Clinically, it is difficult to determine the cause of low ejection fraction whether it is due to depressed contractility or to excessive afterload. Corrective surgery will be more beneficial and will have better outcome when the low ejection fraction is caused by high afterload than when caused by depressed contractility of the myocardium.

References

  1. Lilly LS (editor) (2003). Pathophysiology of Heart Disease (3rd ed. ed.). Lippincott Williams & Wilkins. ISBN 0-7817-4027-4.
  2. Gaasch WH, Levine HJ, Quinones MA, Alexander JK (1976). "Left ventricular compliance: mechanisms and clinical implications". Am J Cardiol. 38 (5): 645–53. PMID 136186.
  3. Marcus ML, Doty DB, Hiratzka LF, Wright CB, Eastham CL (1982). "Decreased coronary reserve: a mechanism for angina pectoris in patients with aortic stenosis and normal coronary arteries". N Engl J Med. 307 (22): 1362–6. doi:10.1056/NEJM198211253072202. PMID 6215582.
  4. Carabello BA (2002). "Clinical practice. Aortic stenosis". N Engl J Med. 346 (9): 677–82. doi:10.1056/NEJMcp010846. PMID 11870246.
  5. Rydén L (1988). "Noninvasive techniques in the evaluation of the arrhythmogenic effects". Eur Heart J. 9 Suppl B: 19–23. PMID 3286263.

Template:WH Template:WS